BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/29/2026 8:41:30 AM | Browse: 86 | Download: 508
Publication Name World Journal of Transplantation
Manuscript ID 119075
Country United States
ISSN 2220-3230 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Transplantation
Manuscript Type Observational Study
Article Title Clinical predictors of SARS-CoV-2 vaccine immunogenicity in kidney transplant recipients at a rural center
Manuscript Source Unsolicited Manuscript
All Author List Debargha Basuli, Bonnie Ross and Lorita M Rebellato
ORCID
Author(s) ORCID Number
Debargha Basuli http://orcid.org/0000-0002-4028-9959
Lorita M Rebellato http://orcid.org/0000-0002-2501-7373
Funding Agency and Grant Number
Corresponding Author Debargha Basuli, Department of Nephrology and Hypertension, Brody School of Medicine, East Carolina University, 2355 W Arlington Blvd, Greenville, NC 27834, United States. basulid17@ecu.edu
Key Words Kidney transplantation; SARS-CoV-2 vaccination; mRNA vaccine; Seroconversion; Immunosuppression; Allograft function
Core Tip In a rural kidney transplant population, fewer than two thirds of recipients developed detectable antibodies after a standard two dose mRNA severe acute respiratory syndrome coronavirus 2 vaccination series. Serologic response was associated with allograft function and antimetabolite exposure, while routine demographic and clinical factors did not predict antibody magnitude among responders. Because immune assessment was limited to a binding antibody assay and clinical outcomes were not evaluated, these findings describe serologic response rather than clinical protection and should be interpreted accordingly.
Publish Date 2026-05-29 08:41
Citation

Basuli D, Ross B, Rebellato LM. Clinical predictors of SARS-CoV-2 vaccine immunogenicity in kidney transplant recipients at a rural center. World J Transplant 2026; 16(2): 119075

URL https://www.wjgnet.com/2220-3230/full/v16/i2/119075.htm
DOI https://dx.doi.org/10.5500/wjt.v16.i2.119075
Full Article (PDF) WJT-16-119075-with-cover.pdf